Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event
    Summit & Event ：
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
    Learn More>
    Wealth & Capital Management
    Insurance & Finance
    Healthcare & Pharma
    Retail & FMCG
    Travel & Transportation
  • Shine Speaker Bureau
    Shine Speaker Bureau：
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
    Learn More>
    The Leader Networks
    Advisor
    Think-Tank
  • Shine Advisor
    Shine Advisor：
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
    Learn More>
    Briefing
    Consensus
    Customized Research
  • Shine Event Service
    Shine Event Service：
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
    Learn More>
Guest Information
Yifei Dai,
Yifei Dai,
发布时间: 2017 - 07 - 05
点击次数: 0
Positions： IDC China Managing Director
Company： Industrial design consultancy (Shanghai) Ltd
个人简介：
Da Yifei, Managing Director of IDC China, with over 15 years’ experience in product research, development and brand commercialization, including many years work experience within the UK innovation industry.As the founding member of IDC China, Fei has led te IDC design and development team alongside Chinese manufacturers to create innovative products and upgrade their brads successfully.During the past few years, IDC successfully created outstanding medical devices such as a breakthrough innovative G3 footdrop device,the first medical glue dispenser in the China market and an electric laryngoscope which achieved the Reddot best of the best award.
查看详情>>
Wenzhi Tian
Wenzhi Tian
发布时间: 2017 - 07 - 05
点击次数: 0
Positions： Chairman & CEO
Company： ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd
个人简介：
Dr. Wenzhi Tian is the founder and Chairman of ImmuneOnco Biopharma Co., Ltd, a start-up company in China, with primary focus of its R&D on tumor immunotherapeutic drugs including checkpoint modulators and target-activated NK (TANK) products that will meet the unmet medical needs both in China and global market.Dr. Tian recently founded ImmuneOnco Biopharma in Zhangjiang Hi-Tech Park dedicating to Research and Development of tumor immunotherapeutic drugs. Dr. Tian returned back to China in April of 2011 from ImClone Systems and established Huabo Biopharm Co., Ltd where he worked as Chief Executive Officer until April of 2015. Dr. Tian joined ImClone Systems as a Research Scientist in January of 2006 and resigned at the position of Principal Research Scientist in April of 2011. Prior to joining ImClone Systems, He was CSO of Aoko Biotechnology Ltd. from July of 2005 to December of 2005, where he was dedicated to developing therapeutic vaccine against HIV using yeast technology platform. Prior to joining Aoko Biotechnology, he was a Senior Research Associate from April of 2001 to Jun of 2005 at the division of immunology, department of medicine, Weill Medical College of Cornell University, with main focus on cloning and characterizing novel genes from B lymphocytes. From October of 1997 to April of 2001, he was a postdoctoral fellow at the division of molecular immunology, department of Rheumatology and Allergy & Immunology, North Shore University Hospital, NYU School of Medicine, dedicated to cloning and characterizing genes involved in Ig class switch recombination. Dr. Tian got his M.D. at Henan Medical University in 1987 and trained as a Ph.D. candidate from 1995 to 1997 at the department of Neurology and Clinical Immunology, Karolinska Institute, Huddinge Unversity Hospital, Huddinge, Sweden.
查看详情>>
Joe Zhou
Joe Zhou
发布时间: 2017 - 07 - 05
点击次数: 0
Positions： Board member and Chief Scientific Officer.
Company： HRYZ BIOTECH CO
个人简介：
Xiangjun Zhou, Ph.D., HRYZ BIOTECH CO. Board member and Chief Scientific Officer. Well-known for his contributions in the field of gene therapy and cancer immunotherapy.1985 BS of Biology, SUN YAT-SEN UNIVERSITY, Guangzhou, China, 1994 MS of Pharmacology, University of Hawaii School of Medicine, Department of Pharmacology, USA, 1997 Ph. D. of Biomedical Science, University of Hawaii School of Medicine, USA, 2000 Post doctoral fellow in Cell Biology, Stanford University School of Medicine Department of Medicine, USA. Lead many important national research grants, Including 863 grants and one 973 grant, Over 20 Publications in Journals such as Science, Journal of Clinical Investigation, Journal of Cell Science, Journal of Biological Chemistry，Filed 10 Patents including US patents such as “Cell-free protein synthesis system with protein translocation and processing”, Patent No: 6,103,489 (Aug. 15, 2000) and China Patents such as “SARS Vaccine”.
查看详情>>
David (Dongliang) Ge
David (Dongliang) Ge
发布时间: 2017 - 07 - 05
点击次数: 0
Positions： CEO & President,
Company： Apostle Inc
个人简介：
Dr. David (Dongliang) Ge is CEO & President of Apostle Inc (http://apostlebio.com), a Silicon-Valley-based biotechnology company developing a novel AI (Artificial Intelligence)-enabled NanoDiagnostics (AID) Technology for cancer detection at the early stage and other diagnosis and treatment of human diseases.Dr. Ge is also appointed as member of U.S. NIH NHGRI Special Emphasis Panel, and Adjunct Assistant Professor at Duke University.Dr. Ge has had extensive experience in leadership roles in both American and Chinese biotechnology industry. Prior to Apostle, he was President of BioSciKin Co., Ltd., a China-based biotechnology company focusing on diagnostics, drug innovation, incubating, investing and licensing. Before BioSciKin, he was Director of Bioinformatics at Gilead Sciences, where he provided leadership to the corporate bioinformatics group and provided strategic input to the precision medicine infrastructure and process. Before Gilead, he was appointed as Assistant Professor of Medicine, Biostatistics and Bioinformatics at Duke University School of Medicine. He received his PhD of Biostatistics and Genetic Epidemiology from Chinese Academy of Medical Sciences in 2004. Dr. Ge was named by the U.S. Genome Technology magazine as one of the “rising stars” in 2009 and by the U.K. Phacilitate as one of the "Top 50 Most Influential People in Big Data" in 2015. At Gilead, he and his colleagues contributed to the clinical development of Sofosbuvir, a world-leading anti-HCV drug. His work in discovering the IL28B genetic variants associated with the hepatitis C patients’ response to clinical treatment, published in Nature in 2009, has received over 3000 citations to date. In total, his work, including 5 original articles in Nature and 1 in Science, has received over 16,000 citations.
查看详情>>
共42条页次8/11首页Previous...  234567891011Next尾页